Despite the success of laser, light, and radiofrequency (RF) treatment of rhytids and laxity, the surgical face-lift remains the gold standard. Evidence-based medicine demands that the validity of a novel treatment is best tested by comparative trial with the gold standard. In this randomized, blinded, quantitative trial, Alexiades-Armenakas et al compared surgical face-lift with a novel, minimally invasive fractional RF system. Using a quantitative measure of laxity, surgical face-lift patients experienced a mean grade improvement of 1.20, while fractional RF patients achieved a 0.44 grade improvement. These data suggest that fractional RF treatment provides an important nonsurgical option for the treatment of photoaging, and they provide a basis for quantifying cosmetic outcomes from novel treatments with valid comparative analysis with the gold standard.